Marsh & McLennan Companies, Inc. (NYSE:MRSH) Stock Has Consensus Target Price of $204.42

Shares of Marsh & McLennan Companies, Inc. (NYSE:MRSH – Get Free Report) have earned a consensus recommendation of “Hold” from the twenty-one brokerages that are covering the stock, Marketbeat Ratings reports. Two investment analysts have rated the stock with a sell recommendation, eleven have assigned a hold recommendation, six have assigned a buy recommendation and two have given a strong buy recommendation to the company. The average 1 year price objective among brokers that have issued a report on the stock in the last year is $204.42.

A number of research analysts have recently issued reports on MRSH shares. Erste Group Bank upgraded Marsh & McLennan Companies to a “strong-buy” rating in a report on Tuesday, September 8th. Cantor Fitzgerald upped their price objective on Marsh & McLennan Companies from $212.00 to $218.00 and gave the stock an “overweight” rating in a research note on Tuesday, July 21st. UBS Group raised their price objective on Marsh & McLennan Companies from $216.00 to $222.00 and gave the company a “buy” rating in a research report on Tuesday, October 6th. Morgan Stanley cut their target price on Marsh & McLennan Companies from $200.00 to $180.00 and set an “equal weight” rating on the stock in a research note on Tuesday, October 6th. Finally, Wells Fargo & Company boosted their target price on shares of Marsh & McLennan Companies from $183.00 to $197.00 and gave the stock an “equal weight” rating in a report on Friday, October 16th.

Read Our Latest Stock Analysis on MRSH

Marsh & McLennan Companies Trading Down 1.8%

NYSE MRSH opened at $191.16 on Friday. Marsh & McLennan Companies has a one year low of $156.60 and a one year high of $200.32. The firm’s 50-day simple moving average is $181.91.

Marsh & McLennan Companies (NYSE:MRSH – Get Free Report) last released its quarterly earnings data on Thursday, October 15th. The financial services provider reported $2.03 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.96 by $0.07. The business had revenue of $6.86 billion for the quarter. The business’s quarterly revenue was up 8.1% compared to the same quarter last year. On average, equities research analysts expect that Marsh & McLennan Companies will post 10.48 EPS for the current year.

Marsh & McLennan Companies Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 13th. Stockholders of record on Thursday, October 1st will be given a $0.99 dividend. The ex-dividend date of this dividend is Thursday, October 1st. This represents a $3.96 dividend on an annualized basis and a dividend yield of 2.1%.

Insider Activity at Marsh & McLennan Companies

In other Marsh & McLennan Companies news, VP Stacy Mills sold 1,215 shares of Marsh & McLennan Companies stock in a transaction on Friday, October 23rd. The shares were sold at an average price of $200.00, for a total value of $243,000.00. Following the transaction, the vice president directly owned 2,705 shares of the company’s stock, valued at approximately $541,000. The trade was a 30.99% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CEO Dean Klisura sold 4,194 shares of the firm’s stock in a transaction on Friday, October 23rd. The stock was sold at an average price of $200.00, for a total value of $838,800.00. Following the completion of the sale, the chief executive officer directly owned 20,935 shares of the company’s stock, valued at $4,187,000. The trade was a 16.69% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 0.38% of the company’s stock.

Hedge Funds Weigh In On Marsh & McLennan Companies

Several hedge funds have recently modified their holdings of the stock. Focus Partners Advisor Solutions LLC purchased a new position in Marsh & McLennan Companies in the second quarter worth $2,153,000. Daiichi Life Insurance Co. Ltd. acquired a new position in shares of Marsh & McLennan Companies during the 2nd quarter worth $3,880,000. Korea Investment CORP acquired a new position in shares of Marsh & McLennan Companies during the 2nd quarter worth $46,856,000. Bank of Nova Scotia purchased a new position in shares of Marsh & McLennan Companies in the 2nd quarter valued at about $20,681,000. Finally, Essex LLC purchased a new position in shares of Marsh & McLennan Companies in the 1st quarter valued at about $2,891,000. Institutional investors and hedge funds own 87.99% of the company’s stock.

Trending Headlines about Marsh & McLennan Companies

Here are the key news stories impacting Marsh & McLennan Companies this week:

  • Positive Sentiment: Marsh & McLennan agreed to issue €600 million of 4.250% senior notes due 2032 and €600 million of 4.625% senior notes due 2036. The offering broadens the company’s European investor base and provides capital for general corporate purposes, potentially supporting financial flexibility. Marsh & McLennan Senior Notes Offering
  • Positive Sentiment: The company expanded its Thrive efficiency program’s annual savings target by 50% to $600 million. If achieved, the higher savings could improve operating margins and earnings, although restructuring expenses and reinvestment may delay the benefits. Expanded Thrive Program
  • Neutral Sentiment: CEO Dean Klisura and Vice President Stacy Mills sold shares under pre-arranged Rule 10b5-1 plans. Mills’ transaction was partly intended to cover tax withholding on vested equity awards, making the sales less indicative of negative insider views, though the transactions may still weigh modestly on sentiment. MRSH Insider Sales
  • Neutral Sentiment: Marsh & McLennan appointed Andy Start CBE as a senior advisor. The move could support strategic and client relationships, but it is unlikely to have a material immediate effect on earnings. Andy Start Senior Advisor Appointment
  • Negative Sentiment: The consensus price target was cut 10.27% to MX$3,381.56, signaling reduced upside expectations. The foreign-currency target is not directly comparable with U.S.-listed MRSH, but the revision can pressure investor sentiment. MRSH Consensus Price Target Cut
  • Negative Sentiment: The new €1.2 billion debt issuance increases interest obligations and leverage, which could temper the benefit of improved market access if borrowing costs or debt levels become investor concerns.

About Marsh & McLennan Companies

(Get Free Report)

Marsh & McLennan Companies is a global professional services firm that provides advice and solutions in risk, strategy and people. The company serves businesses, governments and institutions through a portfolio of specialized businesses focused on insurance brokerage, reinsurance, consulting and talent management.

Its principal businesses include Marsh, an insurance brokerage and risk advisory firm; Guy Carpenter, a provider of reinsurance brokerage and related risk-management services; Mercer, which offers consulting in investment, retirement, health and workforce strategy; and Oliver Wyman, a management consulting firm serving clients across industries and regions.

Founded in 1905, Marsh & McLennan serves clients in countries and markets around the world.

Read More

Analyst Recommendations for Marsh & McLennan Companies (NYSE:MRSH)

Receive News & Ratings for Marsh & McLennan Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marsh & McLennan Companies and related companies with MarketBeat.com's FREE daily email newsletter.